Bristol-Myers Squibb television commercial 2023

What the Bristol-Myers Squibb TV commercial - Multiple Myeloma is about.

Introducing the Bristol-Myers Squibb TV Spot: 'Multiple Myeloma'

: "In a world that sometimes feels overwhelming, where challenges seem insurmountable, Bristol-Myers Squibb is dedicated to making a difference."

: "Multiple Myeloma, a complex form of cancer, can be daunting. But where there is complexity, there is opportunity for breakthroughs."

: "At Bristol-Myers Squibb, we strive to empower patients and their loved ones with the knowledge and support they need to navigate their journey."

: "Our commitment goes beyond innovative treatments and therapies. It extends to a compassionate approach that puts patients first."

: "We understand that by empowering patients, we empower the entire community. Together, we can make strides towards a future where Multiple Myeloma becomes a disease of the past."

: "Bristol-Myers Squibb, committed to the fight against Multiple Myeloma, because every journey begins with hope."

[Tagline: Bristol-Myers Squibb logo and contact information]

[Background Music fades out]

---

Note: The above depiction of the Bristol-Myers Squibb TV Spot is an imaginative portrayal based on the provided context. It aims to highlight the company's dedication to helping patients with Multiple Myeloma, their focus on empowering patients with knowledge and support, and their commitment to finding innovative treatments. Please note that the actual TV spot may differ, as creative adaptions are subject to change based on the marketing and branding strategies of the company.

Bristol-Myers Squibb TV commercial - Multiple Myeloma produced for Bristol-Myers Squibb was first shown on television on February 24, 2023.

Frequently Asked Questions about bristol-myers squibb tv spot, 'multiple myeloma'

Bristol Myers Squibb

A Bristol Myers Squibb research and development facility in Lawrence, New Jersey (corporate headquarters since July 2023)
Total assets	US$96.82 billion (2022)
Total equity	US$31.06 billion (2022)
Number of employees	34,300 (2022)
Website	bms.com

Bristol-Myers Squibb

Drug	Indication	2021 Sales
Eliquis	deep vein thrombosis and pulmonary embolism	$9,168
Opdivo	melanoma, lung cancer, renal cancer	$7,523
Pomalyst	multiple myeloma	$3,332
Orencia	rheumatoid arthritis	$3,306